Cite
HARVARD Citation
Delsing Malmberg, E. et al. (2019). Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML. Leukemia & lymphoma. 60 (2), pp. 409-417. [Online].